Gates Foundation has committed $2.5 billion to accelerate research and development focused exclusively on women’s health.
The foundation in a statement yesterday announced that the investments which run through to 2030, would catalyse innovation in maternal, menstrual, gynaecological and sexual health for women globally.
It disclosed that the support would advance more than 40 innovations in five critical and chronically underfunded areas—particularly those affecting women in low-and middle-income countries.
It submitted that research on women’s health remain chronically underfunded, especially in areas such as gynaecological and menstrual health, obstetric care, contraceptive innovation, Sexually Transmitted Infections, STIs, solutions (including HIV PrEP for women) and maternal health and nutrition.
The foundation referenced a 2021 McKinsey and Company report which showed that one percent of healthcare research and innovation is invested in female-specific conditions beyond oncology.
Critical issues like preeclampsia, gestational diabetes, heavy menstrual bleeding, endometriosis and menopause, which together affect hundreds of millions of women, remain deeply under-researched.
President of Gates Foundation’s Gender Equality Division, Dr Anita Zaidi said “for too long, women have suffered from health conditions that are misunderstood, misdiagnosed or ignored.
“We want this investment to spark a new era of women-centred innovation—one where women’s lives, bodies and voices are prioritised in health research.
“This is the largest investment we have ever made in women’s health research and development, but it still falls far short of what is needed in a neglected and underfunded area of huge human need and opportunity.
“Women’s health is not just a philanthropic cause—it is an investable opportunity with immense potentials for scientific breakthroughs that could help millions of women.
“What is needed is the will to pursue and follow through.”
Similarly, Chairman of the Gates Foundation, Mr Bill Gates said “investing in women’s health has a lasting impact across generations.
“It leads to healthier families, stronger economies and a just world.
“Yet women’s health continues to be ignored, underfunded and sidelined. Too many women still die from preventable causes or live in poor health. That must change. But we cannot do it alone.”
To close persistent gap in funding and research, the foundation urged governments, philanthropists, investors and the private sector to co-invest in women’s health innovations and help shape product development.
It also urged them to ensure access to treatment for women and girls who need them the most.
The foundation disclosed that the five priority areas were selected based on a combination of data and evidence about where innovation can save and improve the most lives.
It emphasised that it was a direct insight from women in low-and middle-income countries about their needs and preferences, and the persistently high rate of misdiagnosis caused by gap in medical knowledge and training.
Professor of Obstetrics and Gynaecology at the College of Medicine, University of Lagos, Bosede Afolabi said “we see the consequences of underinvestment in women’s health innovation every day when they suffer needlessly, and sometimes lose their lives, because of the gap in how we understand and treat conditions that uniquely affect them.
“This commitment brings the much-needed attention to the health challenges that women face in places where resources are most limited and the burden is highest.
“It reflects a recognition that women’s lives—and the innovations that support them—must be prioritised everywhere.”
By addressing long-standing gap in women’s health, the investment aims to unlock broader social and economic gains.
